Using zolmitriptane to prevent childhood migraines
Zolmitriptane as Prophylactic Therapy Childhood Migraine
This study tests if zolmitriptane can help prevent migraines in children better than two other treatments, topiramate and valproate.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 8 Years to 18 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, Kafrelsheikh) |
| Trial ID | NCT06089356 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of zolmitriptane as a prophylactic treatment for childhood migraines. It involves 90 children with migraines, divided into three groups: one receiving zolmitriptane, another receiving topiramate, and the last receiving valproate. The goal is to compare the efficacy of zolmitriptane against these other treatments. The study is designed to provide insights into the best preventive options for managing migraines in children.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with migraines.
Not a fit: Patients with ischemic heart disease or allergies to any of the drugs used will not benefit from this study.
Why it matters
Potential benefit: If successful, this could provide a new effective option for preventing migraines in children.
How similar studies have performed: While there have been studies on migraine treatments, the specific use of zolmitriptane as a prophylactic in children is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: children with migraine - Exclusion Criteria: those who suffer from ischemic heart disease , or who have allergy to any of drugs used -
Where this trial is running
Tanta, Kafrelsheikh
- Kafrelsheikh University — Tanta, Kafrelsheikh, Egypt (Recruiting)
Study contacts
- Principal investigator: Abeer Salamah, ass prof — kafrelsheikh university- egypt
- Study coordinator: abeer salamah, ass prof
- Email: abeersalamah84@yahoo.com
- Phone: 00201009221243
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.